Anavex Life Sciences's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Anavex Life Sciences is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is €-0.10. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -10.54M	$ -12.17M	$ -13.07M	$ -14.52M	$ -15.02M
EBITDA	$ -10.54M	$ -12.17M	$ -13.07M	$ -14.52M	$ -15.02M
Net Income Common Stockholders	$ -8.62M	$ -10.15M	$ -11.28M	$ -13.11M	$ -12.97M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 143.76M	$ 151.02M	$ 154.82M	$ 153.47M	$ 143.62M
Total Assets	$ 148.07M	$ 154.39M	$ 157.81M	$ 159.19M	$ 148.37M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -143.76M	$ -151.02M	$ -154.82M	$ -153.47M	$ -143.62M
Total Liabilities	$ 12.49M	$ 12.53M	$ 11.06M	$ 14.02M	$ 13.25M
Stockholders Equity	$ 135.57M	$ 141.85M	$ 146.75M	$ 145.17M	$ 135.12M
Cash Flow	-
Free Cash Flow	$ -7.32M	$ -5.85M	$ -7.65M	$ -8.49M	$ -5.79M
Operating Cash Flow	$ -7.32M	$ -5.85M	$ -7.65M	$ -8.49M	$ -5.79M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ 59.00K	$ 2.06M	$ 9.00M	$ 18.33M	$ 258.24K

Currency in USD

Anavex Life Sciences Earnings and Revenue History

Income Statement >

Anavex Life Sciences Debt to Assets

Balance Sheet >

Anavex Life Sciences Cash Flow

Cash Flow >

Anavex Life Sciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing